About
Technology
Issues
FAQ
Links
Official Page
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.